...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Thoughts on ZCC

All good points.  Hopefully we'll get good news soon and the shares I have been buying will turn out to be a bargain price. 

Share
New Message
Please login to post a reply